AI assistant
Sending…
STAAR SURGICAL CO — Director's Dealing 2023
Mar 9, 2023
31996_dirs_2023-03-08_1d48f0f7-8383-4519-8712-78dd1738cb01.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: STAAR SURGICAL CO (STAA)
CIK: 0000718937
Period of Report: 2023-03-07
Reporting Person: Francese James E (Sr. VP, Comm. Ops., NA, APAC)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2023-03-07 | Common Stock | F | 672 | $58.13 | Disposed | 34236 | Direct |
| 2023-03-07 | Common Stock | M | 1083 | $58.13 | Acquired | 35319 | Direct |
Footnotes
F1: Performance Stock Units (PSUs) converted into common shares on a one-to-one basis, with the amount representing the vesting of PSUs awarded on March 7, 2022, with achievement based on the Corporation's satisfaction of pre-established financial metrics.
More from STAAR SURGICAL CO
Interim / Quarterly Report
2026
May 13
Regulatory Filings
2026
May 13
Major Shareholding Notification
2026
May 12
Annual Report
2026
May 4
Proxy Solicitation & Information Statement
2026
May 4
Proxy Solicitation & Information Statement
2026
May 4
Major Shareholding Notification
2026
Apr 24
Major Shareholding Notification
2026
Apr 20
Regulatory Filings
2026
Apr 8
Major Shareholding Notification
2026
Mar 27